Utility of coronary revascularization in patients with ischemic left ventricular dysfunction

医学 血运重建 心脏病学 内科学 经皮冠状动脉介入治疗 传统PCI 心肌梗塞 比例危险模型
作者
Mohammed Al‐Sadawi,Michael Tao,Simrat Dhaliwal,Archanna Radakrishnan,Yang Liu,Chad Gier,Ravi Masson,Tahmid Rahman,Edlira Tam,Noelle Mann
出处
期刊:Cardiovascular Revascularization Medicine [Elsevier]
卷期号:65: 88-97
标识
DOI:10.1016/j.carrev.2024.02.021
摘要

Revascularization in patients with left ventricular (LV) dysfunction has been a subject of ongoing uncertainty and conflicting results. This is further complicated by factors including viability, severity of LV dysfunction, and method of revascularization using percutaneous coronary intervention (PCI) versus coronary-artery bypass grafting (CABG). The purpose of this meta-analysis is to evaluate the association of coronary revascularization with outcomes in patients with ischemic LV dysfunction. A literature search was conducted for studies reporting on cardiovascular outcomes after revascularization compared to optimal medical therapy (OMT) in patients with ischemic LV dysfunction. A total of 23 studies with 10,110 participants met inclusion criteria. Revascularization was significantly associated with lower all-cause mortality and CV mortality compared to OMT. The association was statistically significant regardless of severity of LV dysfunction or method of revascularization. Subgroup analysis demonstrated that revascularization was significantly associated with lower all-cause and CV mortality compared to OMT for patients with viable myocardium and mixed cohorts with variable viability, but not patients without viable myocardium. Revascularization was not associated with a significant difference in risk of heart failure (HF) hospitalization or acute myocardial infarction (AMI) compared to OMT. Revascularization in patients with ischemic LV dysfunction is associated with lower risk of all-cause and CV mortality independent of severity of LV dysfunction or method of revascularization. Revascularization is not associated with lower risk of mortality in patients without evidence of viable myocardium and is not associated with lower risk of AMI or HF hospitalization.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研小lese完成签到,获得积分10
刚刚
刚刚
肖思羽完成签到,获得积分10
刚刚
张九霄完成签到,获得积分10
1秒前
Lynn发布了新的文献求助10
1秒前
HAMS发布了新的文献求助10
1秒前
DQ8733发布了新的文献求助10
2秒前
面壁者七號完成签到,获得积分10
2秒前
2秒前
Dr W完成签到 ,获得积分10
2秒前
3秒前
shr完成签到,获得积分10
4秒前
骚猪桶完成签到 ,获得积分10
4秒前
诗剑逍遥完成签到,获得积分10
4秒前
林小雨完成签到,获得积分10
4秒前
完美世界应助丰富又槐采纳,获得10
5秒前
5秒前
Harlotte完成签到 ,获得积分10
5秒前
王浩宇发布了新的文献求助10
5秒前
5秒前
三脸茫然完成签到 ,获得积分10
6秒前
爱听歌白梅完成签到,获得积分10
7秒前
7秒前
7秒前
kekekelili完成签到,获得积分10
8秒前
努力毕业的瓜完成签到,获得积分10
8秒前
kokoka完成签到 ,获得积分10
8秒前
8秒前
987654发布了新的文献求助10
8秒前
迷路的曼梅完成签到,获得积分10
9秒前
YUYUYU应助shangshangqian采纳,获得10
9秒前
zzq229完成签到,获得积分10
9秒前
9秒前
开心绿柳完成签到,获得积分10
10秒前
沙漏发布了新的文献求助10
10秒前
科研通AI2S应助王浩宇采纳,获得10
10秒前
科研通AI2S应助王浩宇采纳,获得10
10秒前
科研通AI2S应助王浩宇采纳,获得10
10秒前
10秒前
大鲨鱼完成签到,获得积分10
11秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
A Dissection Guide & Atlas to the Rabbit 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3134291
求助须知:如何正确求助?哪些是违规求助? 2785137
关于积分的说明 7770495
捐赠科研通 2440760
什么是DOI,文献DOI怎么找? 1297506
科研通“疑难数据库(出版商)”最低求助积分说明 624987
版权声明 600792